Suchergebnisse - "Infantino, Maria"

PubPharm (8)

1

Immunogenicity after two and three doses of mRNA vaccine in patients with cancer treated with exclusive radiotherapy

enthalten in: International immunopharmacology | 2023

von Scoccianti, S. | Delli Paoli, C. | Infantino, M. | +19

2

Booster dose of SARS-CoV-2 messenger RNA vaccines strengthens the specific immune response of patients with rheumatoid arthritis : A prospective multicenter longitudinal study

enthalten in: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2022

von Farroni, C. | Aiello, A. | Picchianti-Diamanti, A. | +31

3

Assessing T-Cell Immunity in Kidney Transplant Recipients with Absent Antibody Production after a 3rd Dose of the mRNA-1273 Vaccine

enthalten in: International journal of molecular sciences | 2022

von Infantino, M. | Tsalouchos, A. | Russo, E. | +10

4

Role of booster with BNT162b2 mRNA in SARS-CoV-2 vaccination in patients with rheumatoid arthritis

enthalten in: Immunologic research | 2022

von Benucci, M. | Damiani, A. | Gobbi, F. | +4

5

The role of neutralizing antibodies by sVNT after two doses of BNT162b2 mRNA vaccine in a cohort of Italian healthcare workers

enthalten in: Clinical chemistry and laboratory medicine | 2022

von Infantino, M. | Manfredi, M. | Stacchini, L. | +12

6

Assessment of humoral and cellular immunity induced by the BNT162b2 SARS-CoV-2 vaccine in healthcare workers, elderly people, and immunosuppressed patients with autoimmune disease

enthalten in: Immunologic research | 2021

von Malipiero, G. | Moratto, A. | Infantino, M. | +8

7

Correspondence on "SARS-CoV-2 vaccination in rituximab-treated patients : evidence for impaired humoral but inducible cellular immune response"by Bonelli et al

enthalten in: Annals of the rheumatic diseases | 2021

von Benucci, M. | Damiani, A. | Infantino, M. | +5

CommentOn: Ann Rheum Dis. 2021 Oct;80(10):1355-1356. - PMID 33958323

8

Presence of specific T cell response after SARS-CoV-2 vaccination in rheumatoid arthritis patients receiving rituximab

enthalten in: Immunologic research | 2021

von Benucci, M. | Damiani, A. | Infantino, M. | +5

1
[1]